Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marin

Showing results (431-440 of 453) with videos related to

Pageof 46
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2026
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in HepatoblastomaLuz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte, et al.
Journal of Hepatology|February 27, 2017
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinomaMaite Merino-Azpitarte, Elisa Lozano, María J Perugorria, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
International Journal of Molecular Sciences|December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver FibrosisMaria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Pageof 46

Showing results (431-440 of 453) with videos related to

Sort By:
Pageof 46
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2026
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in HepatoblastomaLuz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte, et al.
Journal of Hepatology|February 27, 2017
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinomaMaite Merino-Azpitarte, Elisa Lozano, María J Perugorria, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Rhinology|September 10, 2025
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR)G Mortuaire, S F Seys, J de Kinderen, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
International Journal of Molecular Sciences|December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver FibrosisMaria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Pageof 46